4
Changes in Ownership
PUMA BIOTECHNOLOGY, INC. Filed Acc 0001437749-25-020713
Director sold 11,610 shares at $3.40 ($39,474)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dorval Allison Director | 2025-06-13 | Sale 10b5-1 | −11,610 | $3.40 | $39,474 | 75,390 | D |
| Open-market sales · 11,610 sh · avg $3.40 · $39,474 | |||||||
Loading xslF345X05/rdgdoc.xml…